Prevalence of Pseudomonas aeruginosa in cholesteatoma patients in tertiary care hospital in North India

Authors

  • Vikram Singh Rathore Department of ENT, PIMS, Udaipur, Rajasthan, India
  • Kamlesh Kanwar Shekhawat Department of Anesthesiology, PIMS, Udaipur, Rajasthan, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20175084

Keywords:

Ear discharge, Chronic suppurative otitis media, Cholesteatoma, Perioperative

Abstract

Background: Chronic suppurative otitis media (CSOM) is middle ear infection that lasts for more than three months and is accompanied by a perforation of tympanic membrane. Cholesteatoma is a well know complication of CSOM. Prevalence of CSOM varies between racial and socioeconomic groups. The aim of present study was to determine the principal bacteria in ear discharge in patients with cholesteatoma.

Methods: This was a prospective study conducted in department of ENT in tertiary care hospital and medical college in north India from March 2017 to May 2017.Total 80 patients attended ENT OPD with complain of ear discharge and deafness during the study period, but only 47 patients were clinically diagnosed unsafe type of CSOM or cholesteatoma. Ear swabs were collected and send for microbiology laboratory for bacteriological process.  

Results: Out of 80 patients, 47(58.75%) were clinically diagnosed cholesteatoma and of 29(61.70%) were male and 18(38.29%) were female. Most commonly affected age group was between 10 to 20 year (40.42%) followed by 21 to 30 (21.27%). More than 60 Year was less affected by cholesteatoma. Most common isolated organism was Pseudomonas aeruginosa (66.66%) followed by Klebsiella pneumonia (19.44%) and we used Piperacillin tazobactum and amikacin, and ciprofloxacin in all cases in perioperative period and noticed good response and modified radical mastoidectomy was done in all patients.

Conclusions: P. aeruginosa was found to be the most common isolate in CSOM with cholesteatoma case and piperacillin-tazobactum, amikacin, and ciprofloxacin was found to be cost effective antibiotics.

Author Biography

Kamlesh Kanwar Shekhawat, Department of Anesthesiology, PIMS, Udaipur, Rajasthan, India

anesthesiology

References

Tony W, Harold L. Introduction of middle ear and mastoid disease. Disease of the ear. London, UK; 1998: 6.

Nunez DA, Browning GG. Risk of developing an otogenic intracranial abscess. J Laryngol Otol. 1990;104:468-72.

Abramson M, Gantz BJ, Asarch RG, Litton WB. Cholesteatoma pathogenesis: Evidence for the migration theory. In: McCabe B, Sade J, Abramson M eds. Cholesteatoma. First international conference. Aesculapius: Birmingham. 1977: 176-86.

Michaels L. An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol. 1986;15:169-74.

Kurihara A, Toshima M, Yuasa R, Takasaka T. Bone destruction mechanism in chronic otitis media with cholesteatoma: Specific production by cholesteatoma in culture of bone-resorbing activity attributable to interleukin 1 alpha. Annals Otol Rhinol Laryngol. 1991;100:989-98.

Hoshino T, Ishisaki H, Iwasaki S, Sakai T. Osteoplastic changes in attic cholesteatoma. J Laryngol Otol. 1995;109:703-6.

Berman S. Otitis media in developing countries. Paediatrics. 1995;96:126–31.

Wiwanitkit S, Wiwanitkit V. Pyogenic brain abscess in Thailand. N Am J Med Sci. 2012;4:245–8.

MacFaddin J. Biochemical Tests for Identification of Medical Bacteria. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1976.

Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scott's Diagnostic Microbiology. 10th ed. St Louis, Misssouri, USA: Mosby Inc; 1998.

Harker LA, Koontz FP. The bacteriology of cholesteatoma. In McCabe BF, Sade J, Abramson M, eds. Cholesteatoma: First international conference. Aesculapius: Birmingham; 1977: 264-267.

Rivas Lacarte MP, Casasin T, Alonso A. Effects of sodium hyaluronate on tympanic membrane perforation. J Int Medical Res.1992;20:353-9.

Fombeur JP, Barrault S, Koubbi G, Laurier JN, Ebbo D, Lecomte F, et al. Study on the efficacy and safety of ciprofloxacin in treatment of chronic otitis. Chemotherapy. 1994;40:29-34.

Karma P, Jokipil L, Ojala K, Jokipil AMM. Bacteriology of the chronically discharging middle ear. Acta Otolaryngologica. 1978;86:110-4.

Ricciardiello F, Cavaliere M, Lengo M. Notes on the microbiology of cholesteatoma: clinical finding and treatment. Acta Otorhinolaryngol Italica. 2009;29(4):197-202.

Poorey VK, Iyer A. Study of bacterial flora in CSOM and its clinical significance. Indian J Otolaryngol Head Neck Surg. 2002;54(2):91-9.

Aslam MA, Ahmed Z, Azim R. Microbiology and drug sensitivity patterns of chronic suppurative otitis media. J Coll Physician Surg Pak. 2004;14:459-61.

Rama Rao M, Jayakar PA. Bacteriological study of CSOM. J Ind Med Ass. 1980;75:30-3.

Rao BN, Reddy MS. Chronic otitis media: a prospective study. Indian J Otolaryngol Head Neck Surg. 1994;3:126-30.

Greval RS, Ram S. Bacteriological pattern of Chronic Suppurative Otitis Media in Ludhiana. Indian J of Med Sci. 1996;50(6):192-5.

Brook I. Bacteriology of intracranial abscess in children. J Neurosurg. 1981;54:484-8.

Brook I. The role of anaerobic bacteria in otitis: microbiology, pathogenic and implication on therapy. Am J Otolaryngol. 1987;8:109-17.

Downloads

Published

2017-12-22

Issue

Section

Original Research Articles